U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H18Cl2N2O2
Molecular Weight 377.264
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CIPRAZAFONE

SMILES

CN(C(=O)CNC1CC1)C2=CC=C(Cl)C=C2C(=O)C3=CC=CC=C3Cl

InChI

InChIKey=GUHPHHSNJRSHLJ-UHFFFAOYSA-N
InChI=1S/C19H18Cl2N2O2/c1-23(18(24)11-22-13-7-8-13)17-9-6-12(20)10-15(17)19(25)14-4-2-3-5-16(14)21/h2-6,9-10,13,22H,7-8,11H2,1H3

HIDE SMILES / InChI

Description

Ciprazafone is a drug discovered in the 1980s by Pierre Fabre S.A.. It is claimed to have anxiolytic and anticonvulsant properties.

Approval Year

Unknown
149124
Name Type Language
4'-CHLORO-2'-(O-CHLOROBENZOYL)-2-(CYCLOPROPYLAMINO)-N-METHYLACETANILIDE
Preferred Name English
CIPRAZAFONE
INN  
INN  
Official Name English
ciprazafone [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C264
Created by admin on Mon Mar 31 18:31:55 GMT 2025 , Edited by admin on Mon Mar 31 18:31:55 GMT 2025
Code System Code Type Description
FDA UNII
8RSD11181G
Created by admin on Mon Mar 31 18:31:55 GMT 2025 , Edited by admin on Mon Mar 31 18:31:55 GMT 2025
PRIMARY
EPA CompTox
DTXSID20868366
Created by admin on Mon Mar 31 18:31:55 GMT 2025 , Edited by admin on Mon Mar 31 18:31:55 GMT 2025
PRIMARY
EVMPD
SUB07466MIG
Created by admin on Mon Mar 31 18:31:55 GMT 2025 , Edited by admin on Mon Mar 31 18:31:55 GMT 2025
PRIMARY
SMS_ID
100000081519
Created by admin on Mon Mar 31 18:31:55 GMT 2025 , Edited by admin on Mon Mar 31 18:31:55 GMT 2025
PRIMARY
ChEMBL
CHEMBL2104597
Created by admin on Mon Mar 31 18:31:55 GMT 2025 , Edited by admin on Mon Mar 31 18:31:55 GMT 2025
PRIMARY
INN
5451
Created by admin on Mon Mar 31 18:31:55 GMT 2025 , Edited by admin on Mon Mar 31 18:31:55 GMT 2025
PRIMARY
NCI_THESAURUS
C78000
Created by admin on Mon Mar 31 18:31:55 GMT 2025 , Edited by admin on Mon Mar 31 18:31:55 GMT 2025
PRIMARY
PUBCHEM
193989
Created by admin on Mon Mar 31 18:31:55 GMT 2025 , Edited by admin on Mon Mar 31 18:31:55 GMT 2025
PRIMARY
CAS
75616-03-4
Created by admin on Mon Mar 31 18:31:55 GMT 2025 , Edited by admin on Mon Mar 31 18:31:55 GMT 2025
PRIMARY
ACTIVE MOIETY
Structure of CIPRAZAFONE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966